Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis

被引:16
作者
Nikolaou, Vassiliki [1 ]
Papadavid, Evangelia [1 ]
Ekonomidi, Afroditi [1 ]
Dalamaga, Maria [2 ]
Marinos, Leonidas [3 ]
Stratigos, Alexandros [1 ]
Papadaki, Theodora [3 ]
Antoniou, Christina [1 ]
机构
[1] Univ Athens, Sch Med, Andreas Syggros Hosp, Dept Dermatol, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Clin Biochem, GR-11527 Athens, Greece
[3] Evangelismos Med Ctr, Hematopathol Dept, Athens, Greece
关键词
Lymphoma and Hodgkin disease; prognostication; chemotherapeutic approaches; CLASSIFICATION; PROGNOSIS; SUBTYPE; VARIANT; EORTC;
D O I
10.3109/10428194.2014.958821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lymphomatoid papulosis (LyP) refers to an indolent cutaneous lymphoma. The association of prognostic clinicopathological risk factors with a second hematologic malignancy has not yet been determined. We investigated the prognostic effect of clinicopathological characteristics on the occurrence of a second lymphoma, as well as the first-line treatment, in 24 patients diagnosed with LyP using logistic regression models. We showed that lymphoma occurrence was associated with a lower mean age at onset of LyP symptoms, histological types B and C, head-located LyP lesions and a higher frequency of LyP recurrences. In multivariate analyses, histologic type A was associated with a lower risk of second lymphoma (odds ratio [OR] = 0.12, 95% confidence interval [CI] 0.014-0.98; p = 0.045) adjusting for age of LyP first symptomatology, and an important increased lymphoma-free survival rate (long-rank test; p = 0.06). Clinicopathological characteristics are important in defining the clearance or persistence of LyP lesions and may predict the occurrence of a second lymphoma.
引用
收藏
页码:1303 / 1307
页数:5
相关论文
共 33 条
[1]  
Basarab T, 1998, BRIT J DERMATOL, V139, P630
[2]   Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].
Bekkenk, MW ;
Geelen, FAMJ ;
Vader, PCV ;
Heule, F ;
Geerts, ML ;
van Vloten, WA ;
Meijer, CJLM ;
Willemze, R .
BLOOD, 2000, 95 (12) :3653-3661
[3]  
BELJAARDS RC, 1992, BRIT J DERMATOL, V126, P596
[4]   LYMPHOMATOID PAPULOSIS - A T-CELL DYSCRASIA WITH A PROPENSITY TO TRANSFORM INTO MALIGNANT-LYMPHOMA [J].
CABANILLAS, F ;
ARMITAGE, J ;
PUGH, WC ;
WEISENBURGER, D ;
DUVIC, M .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (03) :210-217
[5]  
CHRISTENSEN HK, 1994, SEMIN DERMATOL, V13, P197
[6]  
Dalle Stephane, 2006, Dermatol Online J, V12, P9
[7]   In search of prognostic indicators for lymphomatoid papulosis: A retrospective study of 123 patients [J].
de Souza, Aieska ;
el-Azhary, Rokea A. ;
Camilleri, Michael J. ;
Wada, David A. ;
Appert, David L. ;
Gibson, Lawrence E. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (06) :928-937
[8]   Lymphomatoid papulosis - Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C [J].
El Shabrawi-Caelen, L ;
Kerl, H ;
Cerroni, L .
ARCHIVES OF DERMATOLOGY, 2004, 140 (04) :441-447
[9]   LYMPHOMATOID PAPULOSIS - A CLINICAL AND HISTOPATHOLOGIC REVIEW OF 53 CASES WITH LEUKOCYTE IMMUNOPHENOTYPING, DNA FLOW-CYTOMETRY, AND T-CELL RECEPTOR GENE REARRANGEMENT STUDIES [J].
ELAZHARY, RA ;
GIBSON, LE ;
KURTIN, PJ ;
PITTELKOW, MR ;
MULLER, SA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (02) :210-218
[10]   Lymphomatoid papulosis: Clinical and pathological findings in 18 patients [J].
Fernandez-Guarino, M. ;
Carrillo-Gijon, R. ;
Jaen-Olasolo, P. .
ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 (05) :388-393